This 1 Canadian Cannabis Giant Just Became Bigger

Canopy Growth has had a strong start to the year, and its performance could only get better after its major acquisition deal.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Canopy Growth (TSX:WEED)(NYSE:CGC) is one of the largest Canadian cannabis companies that led the charge, as the legalization boom took place. It also suffered a drastic pullback as speculation died down. After a significant period of remaining low key, Canopy was off to a fantastic start for 2021.

Canopy’s valuation almost doubled between January 1 and February 10, 2021. After reaching its peak, the stock slumped again and is almost down to where it began this year. At its current price, many investors might have good reasons to consider it a good entry point for massive upside potential.

One of the reasons to account for this optimism could be the company’s growth trajectory. Canopy Growth remains one of the largest players in Canada’s legal weed industry. It has grown through both organic means and by acquiring other companies.

The company is sparking a lot of interest due to its latest acquisition that could make Canopy a good stock to keep a close eye on right now.

Canopy’s latest acquisition

Canopy recently announced that it acquired Toronto-based Supreme Cannabis (TSX:FIRE) in a $435 million deal. This acquisition deal is widely being considered as a positive move among investors who are bullish on Canopy’s domination in the domestic weed market.

Supreme Cannabis is among the more prominent operators in the recreational cannabis market in the country. The move seems bullish for investors who are banking on Canada’s growing recreational cannabis market — a market that has grown considerably over the last 12 months.

The country’s adoption of cannabis was slow at the start but has recently picked up the pace. If Canopy continues absorbing competition and growing its domestic market share, it can improve its margins and become more profitable for investors in the coming years.

Supreme is one of the few operators in the industry with a positive adjusted EBITDA in recent quarters. The company has taken several measures to become profitable, and its revenues are increasing rapidly. Canopy has been seeking deals that could positively impact its top and bottom lines. Acquiring Supreme Cannabis seems like the perfect deal for this purpose.

Foolish takeaway

Despite the positive news, it is important to remember that the move primarily improves Canopy’s position in the Canadian cannabis market.

Investors bullish on cannabis legalization across the southern border in the U.S. might not benefit from the deal. Canopy Growth has made significant inroads in the U.S. market but is still locked out of the THC market, like most of its Canadian peers.

The possibility of THC sales in the U.S. could spell great news for Canopy Growth and its peers. Until that comes to pass, the acquisition might significantly boost the company’s performance in the domestic market.

Canopy has been growing its revenues at a steady pace, and its losses are slowly shrinking. While the stock might not be undervalued, the chances of it seeing long-term growth are increasing. It could still face issues in the short term, but Canopy might be an ideal long-term buy for investors who are bullish on the growing cannabis industry.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »